- Acadia taps interim CFO amid finance chief’s departure
- Connecticut fines 5 insurers over alleged mental health parity violations
- Payer pressure, hospital cost limits and a split workforce: 3 signals to watch
- The legislation that could change dentistry’s trajectory
- Virtual visits effective for new neurology patients: Study
- Beebe Healthcare names chief philanthropy officer of medical foundation
- How dental AI is addressing 3 of dentistry’s most pressing issues
- Pancreatic cancer pill, vaccine show promise: What to know
- Median PA pay by state
- How CEOs and CFOs can find common ground
- Moffitt Cancer Center taps VP of payer strategies
- Encompass Health CIO retires
- Keck Medicine, Tempus AI ink precision medicine partnership
- HCA Texas system taps regional VP of HR
- FTC reaches preliminary settlement with US Anesthesia Partners
- Outpatient surgery grows as access gaps persist: Study
- Dental technology company secures $22M investment
- Meadows Behavioral Health center rebrands, expands services
- California dentist sentenced for sexual battery of patients
- Louisiana lawmakers advance bill to expand Medicaid coverage for dental procedures
- Who’s winning the ASC race?
- Orthodontics technology company promotes executive leaders
- Premier Care Dental Management’s growth in 2026: 6 moves
- IR Centers, New Jersey Urology to open multiple outpatient centers
- Optum’s turnaround ahead of schedule: Execs
- Justice Department reclassifies marijuana products: What it means for healthcare
- AI-powered prior authorizations for Medicare have greatly delayed care, Washington state hospitals say
- Why dental practice owners are feeling a financial squeeze in 2026
- The region seeing a GI boom
- 5 ASC leaders building the multispecialty platforms of the future
- Tenet exec pay by the numbers
- What the dental industry can learn from DSO restructurings
- 3 emerging challenges in dentistry
- The employment vs. independence pressure point
- Cincinnati Children’s appoints psychiatry division director
- FTC files suit over telemarketing scheme selling fake PPO insurance
- What is psilocybin? Inside Trump’s push for psychedelic treatments
- Medical real estate developer breaks ground on $16M MOB
- Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
- Molina strikes 'prudent' tone on 2026 outlook amid positive signs on Medicaid spending
- Regeneron unveils latest 'most favored nation' drug pricing deal with White House
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Drop in NIH Funding Delays Thousands of Studies
- U.K. Plans To Ban Cigarette Sales for Future Generations
- Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
- Roche Q1 earnings suffer blood bath, but currency headwinds aren’t the only culprit
- FDA citizen petition calls on agency to tighten up CRL disclosure practices
- With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity
- Telehealth provider Him & Hers adds all FDA-approved GLP-1s to platform
- CMS, FDA announce new program to speed up Medicare coverage of breakthrough medical devices
- With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- New Treatment, Dato-DXd, Improves Survival for Aggressive Breast Cancer
- ER Study Finds Major Gaps in Measles Immunity
- Most Americans Worried About Brain Health, But Few Know How To Protect It
- IVF 'Add On' Procedure With Hormone Human Chorionic Gonadotropin (hCG) Doesn't Work, Evidence Review Concludes
- More than 60% of Americans using AI tools for medical information: survey
- Evonik to pump €80M into Slovakia production facility, add 50 jobs
- OpenAI launches ChatGPT for Clinicians, a free AI tool for physicians, NPs and pharmacists
- Deerfield trots into pharma sales software space with CRM-enhancing tool
- Merck’s new AI commercial strategy ‘reimagining engagement with HCPs’
- ‘It buys patients time’: GLP-1s show early promise in addiction treatment
- Care New England rolls out Butler Behavioral Health brand
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Grand Canyon University to add 6,000 to behavioral health pipeline
- AMA urges federal oversight of mental health chatbots
- Conservative think tank Paragon Health calls its shots on hospital policy reform
- Amazon One Medical launches GLP-1 program integrated with primary care
- CDC Report on COVID Vaccine Blocked From Publication
- Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss
- RFK Jr. continues congressional hearing appearances to talk White House budget plan
- RFK Jr. Won't Commit to CDC Nominee's Vaccine Decisions
- Pentagon Drops Flu Vaccine Requirement For U.S. Military
- AbbVie to establish NC production base with $1.4B investment, creating 730-plus jobs
- Zocdoc partners with Yelp to allow real-time scheduling
- CMS delays Part D GLP-1 model amid skepticism from insurers
- CMS delays Part D GLP-1 model amid skepticism from insurers
- Amneal seizes 'golden era' for biosims with $1.1B Kashiv buyout
- Samsung Biologics posts massive revenue growth as labor union rally sets stage for strike
- Bullying, Politics Harm Mental Health Of Gender-Diverse Teens
- Male Infertility Linked To Cancer Risk
- Video Game Training Sharpens ER Doctors’ Split-Second Decisions
- Hidden Belly Fat Linked to Bladder Control in Women
- Mind-Controlled Bionic Suit Lets Paralyzed Patients Feel Every Step
- Napping Linked To Higher Risk Of Death Among Seniors, Study Finds
- Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
- Oak HC/FT backs Courier Health's $50M series B to build out AI for the biopharma patient experience
- Elevance Health seeing shift to bronze tier in ACA plans
- Novartis launches ‘Sjöut for Sjögren’s campaign, teams with Carrie Ann Inaba
- Community Health Systems attributes Q1 volumes stumble to consumers' macroeconomic fears, payers' prior auth denials
- Children’s Activity Cubes Recalled Over Choking Hazard Risk
- Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso
- 'Don't be a wimp,' Mark Cuban tells lawmakers hesitant to break up PBMs
- Study Finds AI Chatbots Can Give Misleading Health Advice
- Former Surgeon General Backs CDC Nominee, But Questions Remain on Vaccines
- Cantaloupes Recalled in Four States Due to Salmonella Risk
- Keynote Remarks at The Economic Club of Washington
- Merger to create nation's largest suicide prevention nonprofit
- Oz previews new plan to push states toward revalidating Medicaid providers
- Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
- Covera Health, Medmo combine to create end-to-end diagnostic imaging platform
- The Oral GLP-1 Tracker: Following the launch trajectories of Lilly’s Foundayo, Novo’s Wegovy pill
- Service Dogs Perform Tasks Akin To Human Caregivers, Researchers Say
- A Third Of Young Adults Are Couch Potatoes, Their Parents Say
- Powerful Antibiotic Combo Not Necessary For Simple Sinus Infections, Study Shows
- Black Women Hit Hardest By Pandemic-Related Rise In Pregnancy-Related Deaths
- Smoking, Vaping Weed Increases Risk Of Asthma Attacks Among Young Adults, Study Finds
- Less-Dangerous Painkillers, Gabapentinoids, Still Have High Risk For Drug Interactions
- AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win
- In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
- UnitedHealth Group spotlights AI investments as part of operational turnaround
- ECRI spins out healthcare supply chain division into Staritas, backed by PE firm Accel-KKR
- UCB partners with Myasthenia Gravis Foundation of America on meal program targeting nutrition deserts
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- 'Hospitals adverse to transparency'—clashing industry groups spar on mulligan 340B rebate pilot
- Amperos Health secures $16M in series A funding, unveils AI-native denial management solution
- “PF” Stands for Please Fix: Statement on the Proposed Amendments to Form PF
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Why UnitedHealth Group is betting big on doulas
- AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions
- Baby Food Recalled After Rat Poison Discovered in Jar
- Report Finds Drug Prices Rising Despite Trump Pricing Deals
- Trump Backs Psychedelic Research
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show
- Extra Antibiotic Doesn't Reduce Infection Risk During Surgery To Fix Complex Fractures, Trial Finds
- Clinical Trial Suggests Two Simple Ways To Fight Chemo-Related Brain Fog
- E-Cigarette Taxes Won't Necessarily Cause An Increase In Smoking, Study Says
- Dreams Affect Your Morning Mood In Surprising Ways, Study Finds
- Weed Blunts Brain Development In Teens
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Remarks at the Options Market Structure Roundtable
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Roche’s Enspryng cuts relapse risk by 68% in rare neuroinflammatory disease
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
Nursing ethics is grounded in "inherent dignity, worth, and unique attributes of every person" (ANA) in alignment with principles of Christian liberty and the American Founding.
Medical ethics is older, and traditionally more disease-focused, self-sustaining, and authoritarian. (4 Principles of Biomedical Ethics) Bioethics in particular has made a bad reputation for itself in association with assisted suicide and reduced standards for organ donation/ declaring brain death.
Lippincott makes a fair comparison between the two codes of ethics.
Both have recently strayed from dedication to the individual in their care, and instead toward population care and ESG (environmental, social justice, and governance).
https://www.medpagetoday.com/opinion/second-opinions/118526
In Memoriam: The Sudden Demise of the AMA Journal of Ethics
— A great loss for physicians, the profession, and the public
November 14, 2025
Bioethics is a small field, but we punch above our weight when it comes to writing. Professional journal articles, reports, and policies are arguably our primary written products, since the main job in bioethics is to help clinicians and others navigate ethical challenges in their work. But we also write for the public, in forums like blogs and editorials, since many of the issues we write about have broader implications. Consequently, learning to write for publication is a key skill for bioethicists, and professional journals are critical for the field. One particular journal -- the AMA Journal of Ethics (AMA JoE) -- has been a stalwart in giving a voice to newcomers to the field.
In late October, without warning, the American Medical Association (AMA) announced that it would cease publishing AMA JoE after the December 2025 issue. Journals like AMA JoE operate a year or more in advance, so multiple authors and editors of upcoming issues for 2026-2027 were left in the lurch by this unexpected announcement. Students and trainees are now scrambling to find new homes for their articles, some of which have already undergone extensive editorial review.
The Birth of AMA JoE
For over 25 years, AMA JoE stood out from the rest of bioethics journals. It was a rare monthly open access journal that tackled a remarkably wide variety of topics. The journal has a unique model where students and trainees competitively apply to edit a theme issue of their choosing, and then they work closely with professional editors to pull each issue together. This requires a great deal of work by these editors-in-training, including selecting and pitching a topic, identifying mentors and contributors, editing manuscripts, and coordinating with the journal's professional staff.
AMA JoE initially launched in 1999 as an innovative online resource, the Virtual Mentor. The brainchild of Audiey Kao, MD, PhD, vice president of ethics at the AMA, Virtual Mentor was created with a focus on serving students and trainees in medicine. (Full disclosure: both of us were working in the AMA's ethics group at the time, and we each contributed pieces to early issues of the Virtual Mentor, but we were not involved in creating it.) In 2015, the Virtual Mentor was rebranded as the AMA Journal of Ethics, reflecting the journal's maturity into an indexed, professional journal that, while still using learners as editors, also published peer-reviewed work by leading bioethicists, clinicians, and academics.
Why Did the AMA Kill its Journal of Ethics?
The AMA is the nation's largest and most influential medical professional organization, and its Journal of Ethics held the mission of, "illuminating the art of medicine" by being an open access journal, freely available to all, with no advertising, focusing each month on an important ethical issue in healthcare, and, most uniquely perhaps, each issue was edited by health professional trainees and their mentors. Only the AMA, with its mission, resources, and reach, could have produced this journal.
One possible reason for its elimination might be financial. But if financial returns were to be a metric for success, then the AMA JoE had a bad business model from the start: no fees, no subscriptions, no advertising. As Kao argued, a guiding premise for the journal was that "ethics inquiry is a public good" -- hence no fees or subscriptions and no ads (avoiding conflicts of interest is critical in ethics inquiry).
For the AMA, the business case for AMA JoE could never have been about profit; rather, it was about demonstrating the AMA's integrity, altruism, and service to physicians from very early in their careers. The journal aimed to build goodwill, bolster the AMA's reputation, improve ethical deliberation within the profession and, most importantly, entice students and trainees to engage seriously with the organization. By these metrics it has succeeded. Over its more than 25 years in existence, the journal drew innumerable medical students, residents, and fellows into the AMA. It also provided a crucial training ground for young people in medicine who wanted to learn about bioethics and about writing and editing, and it helped build the credibility and presence of the AMA and its ethics group nationally and internationally.
So, if it wasn't about profit, perhaps it was the political environment. The journal encouraged medical trainees to explore some of the most contentious challenges facing medicine and society, so it inherently provided opportunities for controversy. Issues this year have addressed themes of private equity in medicine, regret and surgical professionalism, and evidence-based design in healthcare. Meanwhile, issues in prior years have addressed some currently inflammatory topics, like ethical issues related to transgender surgical care and segregation in healthcare. Remarkably, the journal still very rarely caused public relations problems for the AMA, perhaps because its editorial staff were highly qualified professionals, but also because its approach to controversy was civil, inquisitive, and exploratory.
As Kao wrote in a farewell essay this month: "For over a quarter of a century, the AMA Journal of Ethics has striven to publish insightful commentaries, engaging podcasts, and provocative artwork that help medical students, physicians, and all health care professionals reflect on and make sound ethical decisions in service to patients and society." In fact, the journal often demonstrated exactly this spirit of respectful discussion about challenging ethical issues that we need to rekindle today, making its loss even more tragic and difficult to explain.
AMA JoE: A Value-Added Offering
In a recent opinion piece in MedPage Today, "Medical Societies Are Facing an Existential Crisis," the authors exhorted medical societies, facing declining memberships and engagement among young physicians, to reimagine their role by offering "free basic memberships supplemented by value-added services [that] could attract early-career physicians who might otherwise remain disengaged." AMA JoE was exactly this type of value-added offering that not only served students and trainees, but also educators across health professions. Anecdotally, many health profession educators we know routinely use pieces from AMA JoE in their teaching and now lament its demise.
The AMA has reportedly promised to keep the historical content of the journal accessible on the AMA JoE website. This is no consolation for the students, residents, and fellows who were working on future issues, but it means the legacy of the journal will live on. Someday, we'd like to believe it might even be revived.
For now, we mourn the loss of AMA JoE for the field of bioethics. Even more, we mourn what the AMA's sudden elimination of its ethics journal might mean for physicians, the profession, and the public.
Matthew Wynia, MD, MPH, is a professor at the University of Colorado School of Medicine and Colorado School of Public Health and director of the Center for Bioethics and Humanities at the University of Colorado, Anschutz Medical Campus. Kayhan Parsi, JD, PhD, is a professor and graduate program director at the Neiswanger Institute for Bioethics at the Loyola University Chicago Stritch School of Medicine. He is also the John B. Francis co-chair in Bioethics at the Center for Practical Bioethics.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





